DORMANT studio
localhost:3000

Opportunity radar

4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05

Showing50 of 30,058
Free-text
CPC starts with (comma sep)
Min fwd citations
Clear
Patent #TitleAssetsIssuedExpiresFwd citesScore
12582598Topical anti-inflammatory pharmaceutical composition comprising Zileuton🖼🧊📄§2026-03-242039-12-30031
12582609Cancer vaccines🖼🧊📄§2026-03-242036-10-21031
12582616Molecular targets for modulation of dissociative and associative states🖼🧊📄§2026-03-242041-08-09031
12582624Co-crystal of gabapentin, ketoprofen and lysine, pharmaceutical compositions and their medical use🖼🧊📄§2026-03-242041-04-21031
12582622Sodium oxybate to treat idiopathic hypersomnia🖼🧊📄§2026-03-242041-10-08031
12582623Composition comprising EPA, MA and leucine for improving muscle function🖼🧊📄§2026-03-242040-10-30031
12582621Compositions and methods for delivering pharmaceutical agents🖼🧊📄§2026-03-242041-06-11031
12582625Methods for treating neuroblastoma🖼🧊📄§2026-03-242044-12-23031
12582627MCT formulations for improving cognitive functions🖼🧊📄§2026-03-242041-05-17031
12582628Methods for treating breast cancer🖼🧊📄§2026-03-242042-04-13031
12582633Methods of treating severe acute respiratory syndrome🖼🧊📄§2026-03-242041-04-08031
12582637Topical formulation for intradermal application and uses thereof🖼🧊📄§2026-03-242039-08-29031
12582640Treatment of lower respiratory tract infection with tradipitant🖼🧊📄§2026-03-242041-03-24031
12582641Sulfur-containing compound based on glutarimide skeleton and application thereof🖼🧊📄§2026-03-242040-02-25031
12582642Composition for treating, improving, and/or preventing progression of bovine papillomatosis caused by bovine papillomavirus🖼🧊📄§2026-03-242041-05-28031
12582646Method for treating drug or alcohol dependency🖼🧊📄§2026-03-242040-01-03031
12582643Tasquinimod or a pharmaceutically acceptable salt thereof for use in combination therapy🖼🧊📄§2026-03-242041-03-03031
12582651Pharmaceutical composition comprising tadalafil or pharmaceutically acceptable salt thereof and dutasteride or pharmaceutically acceptable salt thereof exhibiting novel dissolution rate🖼🧊📄§2026-03-242041-12-30031
12582653Method for treating idiopathic pulmonary fibrosis🖼🧊📄§2026-03-242040-06-24031
12582655Methods of treating disorders using CSFIR inhibitors🖼🧊📄§2026-03-242045-10-21031
12582656Nucleotide analogues🖼🧊📄§2026-03-242041-03-23031
12582657Combination therapy including a KRAS G12C inhibitor and one or more additional pharmaceutically active agents for the treatment of cancers🖼🧊📄§2026-03-242043-12-19031
12582667Compositions and methods to treat metastatic gastrointestinal cancer🖼🧊📄§2026-03-242040-09-25031
12582668Methods for the treatment of alpha-1 antitrypsin deficiency (AATD)🖼🧊📄§2026-03-242040-06-05031
12582674Methods and treatment of trauma🖼🧊📄§2026-03-242043-01-09031
12584105Autologous cell replacement therapy for Parkinson's disease🖼🧊📄§2026-03-242040-05-21031
12582694Compounds and methods for inhibiting protozoan parasites🖼🧊📄§2026-03-242042-05-12031
12582599Methods for treatment of bladder cancer with gemcitabine🖼🧊📄§2026-03-242042-07-07031
12577208TEAD inhibitors and uses thereof🖼🧊📄§2026-03-172043-06-16031
12576070Medicine for improving state of pregnancy, and use thereof🖼🧊📄§2026-03-172042-11-23031
12576100Nucleic acid agents modulating SLAMF6 isoforms🖼🧊📄§2026-03-172040-06-23031
12577312Methods for the treatment of melanoma using compositions of denosumab and PD-1 inhibitor🖼🧊📄§2026-03-172045-02-26031
12580049Tumor microenvironment-based methods for assessing CAR-T and other immunotherapies🖼🧊📄§2026-03-172042-12-23031
12576119Bacteriophage compositions and methods for treatment of bacterial infections🖼🧊📄§2026-03-172045-04-14031
12576138Compounds and methods for the immobilization of myostatin-inhibitors on the extracellular matrix by transglutaminase🖼🧊📄§2026-03-172039-05-17031
12577283Knockdown or knockout of one or more of TAP2, NLRC5, B2m, TRAC, RFX5, RFXAP and RFXANK to mitigate t cell recognition of allogeneic cell products🖼🧊📄§2026-03-172042-01-28031
12577325Bispecific antibody-camptothecin drug conjugate and pharmaceutical use thereof🖼🧊📄§2026-03-172044-11-22031
12577196Quaternary amine compounds with isopropylmethylphenol ester moieties as antivirals, antibacterials and antimycotics🖼🧊📄§2026-03-172040-04-16031
12577222Phenethylamine compounds salts, polymorphic forms and methods of use thereof🖼🧊📄§2026-03-172044-01-19031
12576129Anthelmintic compositions and methods🖼🧊📄§2026-03-172042-09-23031
12576057Antibacterial and biofilm formation-inhibiting composition containing myristoleic acid as active ingredient🖼🧊📄§2026-03-172042-11-18031
12576149Gamma delta T cells derived from induced pluripotent stem cells, and production method therefor🖼🧊📄§2026-03-172045-01-14031
12576053Use of 2-[(3Z)-6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl) methylidenejinden-1-yl] acetic acid🖼🧊📄§2026-03-172038-04-11031
12576058Methods for decreasing injuries associated with intraoperative hypotension🖼🧊📄§2026-03-172044-04-30031
12576123Epitope-based approach for allergy treatments and inhibitors for Crohn's disease🖼🧊📄§2026-03-172040-03-13031
12576154Conjugates of PSMA-binding moieties with cytotoxic agents🖼🧊📄§2026-03-172043-07-31031
12576062Methods using administration of medium chain triglycerides (MCT) prior to a meal to increase ketone production from the MCTs🖼🧊📄§2026-03-172040-03-17031
12576118Bacteriophages for the treatment of tuberculosis🖼🧊📄§2026-03-172040-05-21031
12576045Methods and nutraceutical compositions for the prevention and/or mitigation of veisalgia🖼🧊📄§2026-03-172043-02-06031
12576166Contrast agents for detection of enzyme activities based on melanin synthesis🖼🧊📄§2026-03-172041-07-26031